Cargando…

Reply to Levis and Rendini

Detalles Bibliográficos
Autores principales:	Singh, Dhiraj Kumar, Dwivedi, Ved Prakash, Ranganathan, Anand, Bishai, William R., Van Kaer, Luc, Das, Gobardhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451602/ https://www.ncbi.nlm.nih.gov/pubmed/28199694 http://dx.doi.org/10.1093/infdis/jix084

Ejemplares similares

Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2020)

Correction: Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

The Phytochemical Bergenin Enhances T Helper 1 Responses and Anti-Mycobacterial Immunity by Activating the MAP Kinase Pathway in Macrophages
por: Dwivedi, Ved P., et al.
Publicado: (2017)

Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1β Production in Dendritic Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity
por: Singh, Yogesh, et al.
Publicado: (2013)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner
por: Chatterjee, Samit, et al.
Publicado: (2011)

Transforming Growth Factor-β Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4(+) and CD8(+) T Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

CD4(+) T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4(+) T Cells to Direct T Helper 2 Cell Differentiation
por: Khan, Mohd Moin, et al.
Publicado: (2012)

Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
por: Ahmad, Shaheer, et al.
Publicado: (2019)

Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy
por: Tousif, Sultan, et al.
Publicado: (2017)

Isoniazid Induces Apoptosis Of Activated CD4(+) T Cells: IMPLICATIONS FOR POST-THERAPY TUBERCULOSIS REACTIVATION AND REINFECTION
por: Tousif, Sultan, et al.
Publicado: (2014)

Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis
por: Kumar, Santosh, et al.
Publicado: (2021)

Author's reply
por: Babu, P Ravindra, et al.
Publicado: (2017)

Prostanoid Receptor 2 Signaling Protects T Helper 2 Cells from BALB/c Mice against Activation-induced Cell Death
por: Kaul, Vandana, et al.
Publicado: (2012)

Burden of Clostridium difficile Infections in Québec by Levy et al
por: Longtin, Yves, et al.
Publicado: (2016)

Authors’ Reply
por: Kumar, Piyush, et al.
Publicado: (2016)

Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
por: Devi, Annu, et al.
Publicado: (2023)

A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response
por: Samuchiwal, Sachin Kumar, et al.
Publicado: (2014)

In reply:
por: Nowak, Richard M., et al.
Publicado: (2020)

Reply
por: Singh, Rohan Bir, et al.
Publicado: (2023)

Reply
por: Singh, Shailendra, et al.
Publicado: (2021)

A novel peptide interferes with Mycobacterium tuberculosis virulence and survival
por: Samuchiwal, Sachin Kumar, et al.
Publicado: (2014)

Mycobacterium tuberculosis Subverts the TLR-2 - MyD88 Pathway to Facilitate Its Translocation into the Cytosol
por: Rahman, Md. Aejazur, et al.
Publicado: (2014)

Authors’ Reply
por: Reddy, Raghunatha R, et al.
Publicado: (2012)

T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
por: Tousif, Sultan, et al.
Publicado: (2011)

Antihistamimics in Cholera (A Reply)
por: Chakravarti, H. S., et al.
Publicado: (1954)

Reply
por: Oey, Rosalie C., et al.
Publicado: (2019)

Reply
por: Jackson, Daniel J., et al.
Publicado: (2020)

Reply to Pandita et al
por: Olender, Susan A, et al.
Publicado: (2020)

Reply
por: Philips, Cyriac Abby, et al.
Publicado: (2022)

Authors’ Reply
por: Kumar, Jogender
Publicado: (2020)

The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway
por: Singh, Mona, et al.
Publicado: (2022)

Authors’ Reply
por: Sadath, Haneef Nayeem, et al.
Publicado: (2012)

Reply
por: Vowles, Kevin E., et al.
Publicado: (2015)

Author's reply
por: Pandey, Vaibhav, et al.
Publicado: (2014)

Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q60g0glbccc81gle13irakgjl6